Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AdipoGen Life Sciences is a specialized biotechnology company that develops, manufactures, and markets high-quality research reagents for the global life sciences community. The company is recognized for its expertise in specific areas of biological research, including inflammation, the inflammasome, metabolic syndrome, and immuno-oncology. Its extensive product portfolio features recombinant proteins, functional antibodies, ELISA kits, and small molecule biochemicals. AdipoGen operates with a strong R&D focus, often collaborating with academic experts to bring novel tools to market, such as those targeting IL-33 and NLRP3. Headquartered in Switzerland with major operations in South Korea and the United States, the company provides essential tools for drug discovery and basic research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adipogen Pharmaceuticals.